touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing.
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/treatment-sequencing-in-ms-the-benefits-of-dmts/
What’s new for eosinophilic esophagitis? A case-based discussion of patient care
What’s new for eosinophilic esophagitis? A case-based discussion of patient care
Higher-risk MDS and newly diagnosed AML What are the latest developments from EHA 2022
Advances in the first-line treatment of ES-SCLC: From clinical data to daily practice
Investigating KRAS-G12C inhibitors: How might they improve outcomes for patients with solid tumours?
Improving outcomes for patients with advanced renal cell carcinoma
Experts in paediatric endocrinology discuss the assessment and treatment of children with achondroplasia
Investigating KRAS-G12C inhibitors: How might they improve outcomes for patients with solid tumours?
Current and emerging treatments for chronic myeloid leukaemia: What have we learnt from the EHA Hybrid Conference 2022?
Maximizing the potential of PARP inhibitors as first-line maintenance therapy in ovarian cancer
The practicalities of eosinophilic oesophagitis management: A closer look at emerging biologic treatment options
The practicalities of eosinophilic oesophagitis management: A closer look at emerging biologic treatment options
Breast cancer specialists discuss risk stratification and novel treatment strategies in high-risk HR+ HER2– early breast cancer
How can real-world evidence guide the management of elderly and frail patients with multiple myeloma?
Navigating the challenges of treatment provision in recurrent/metastatic HNSCC
Managing EoE: What options are emerging for patients? - Conversation 3
Symptoms of EoE: What is the burden for patients? - Conversation 2
Pathophysiology of EoE: What do we see in patients? - Conversation 1
Managing EoE: What options are emerging for patients? - Conversation 3
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
The Psychic Elephant Radio Podcast
Museum of the Missing
Sasquatch Chronicles
Hidden Brain